Skoulidis, Ferdinandos
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #8,968
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$1.1M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#8,968
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Skoulidis, Ferdinandos as a PI. Multi-PI records show the full award amount for context.
- 1R01CA279194-01R01Contact PIDissecting and targeting tumor-TME crosstalk to forestall acquired KRASG12C inhibitor resistance in NSCLC.UT MD Anderson Cancer Center · Internal Medicine (NIH department code)$370.6Kaward amount
- 1R01CA272570-01A1R01Contact PIDissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancerUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$370.6Kaward amount
- 5R01CA262469-03R01Contact PIUnderstanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancerUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$363.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Skoulidis, Ferdinandos as a PI.
FY2023 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardUT MD Anderson Cancer Center
- 2022$500K Cumulative Funding
- 2022R01 Grant Holder
- 2023$1M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #8968